Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04771338 · ClinicalTrials.gov registry record · NA
Examining the Effects of a Job Entry Intervention
A NA study, sponsored by Kessler Foundation.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT04771338: Completed NA study, sponsored by Kessler Foundation.
NCT04771338 is a NA study that has completed, run by Kessler Foundation. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04771338, a NA study, has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The current study will examine the efficacy of a virtual reality (VR) intervention as well as a newly developed Kessler Foundation STRength IDentification and Expression tool (VR-STRIDE) with adolescents diagnosed with autism spectrum disorder.
Primary Outcome
Mock Job Interview skills will be assessed by having blinded raters trained to assess job interviews scoring participants across a number of domains including expressing personal strengths and sounding professional. This rating scheme has been used in previous research (Smith et al., 2014; 2015),
Interventions
- BEHAVIORAL VR-JIT/KF-STRIDE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2023-07-26 |
| Phase | NA |
What the finished NCT04771338 record still lists
NCT04771338 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which VR-JIT/KF-STRIDE is the first listed.
NCT04771338 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04771338 about?
NCT04771338 is a clinical study titled "Examining the Effects of a Job Entry Intervention". The current study will examine the efficacy of a virtual reality (VR) intervention as well as a newly developed Kessler Foundation STRength IDentification and Expression tool (VR-STRIDE) with adolescents diagnosed with autism spectrum disorder.
What is the current status of trial NCT04771338?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2019-09-01. Estimated completion is 2023-07-26.
What interventions are being tested in trial NCT04771338?
The interventions under investigation include: VR-JIT/KF-STRIDE (BEHAVIORAL).
Who is sponsoring clinical trial NCT04771338?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04771338's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI